Mohammad Shafi Kuchay

Senior Consultant (Endocrinology and Diabetology)

About

Dr Mohammad Shafi Kuchay is Senior Consultant, Division of Endocrinology and Diabetes in Medanta, Gurugram. He completed his MBBS and MD (Internal Medicine) from Acharaya Shri Chander College of Medical Sciences, Jammu. He pursued DM (Endocrinology) from Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar. Dr. Mohammad Shafi Kuchay specializes in treating diabetes mellitus, thyroid disorders, pituitary & adrenal diseases, osteoporosis, calcium Disorders, polycystic ovary syndrome and other endocrine disorders. He has published several papers in various National and international journals of repute. He is also an editor of Diabetes and Metabolic Syndrome: Clinical Research and Reviews.

List Of Treatments

  • Adrenal disorders

  • Diabetes Mellitus (type 2/type 1/gestational and others)

  • Osteoporosis and Calcium Disorders

  • Polycystic Ovary Syndrome and other Endocrine Disorders

  • Thyroid disorders/Pituitary/Adrenal Diseases

Achievments & awards

Mohammad Shafi Kuchay

  • Education
  • Paper Published

    DM (Endocrinology) Sher-I-Kashmir Institute of medical sciences, Soura, Srinagar 2014 MD(Internal Medicine) Acharaya Shri Chander College of Medical Sciences, Jammu 2010 MBBS with Internship Acharaya Shri Chander College of Medical Sciences, Jammu 2006

Memberships & Certifications

  • Indian Society of Paediatric and Adolescent Endocrinology (ISPAE)

Awards & Accomplishments

  • The Fifth Annual IJEM Awards 2015 for excellence in Endocrine writing, for the paper, “Effect of vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes: A 1-year, open-label randomized study”, 2015
  • Best paper presentation award in annual AE-PCOS conference in AIIMS, New Delhi, in 2011 for the paper, Girls are more insulin resistant than boys at birth using cord blood collections., 2011

Publications

  • Related metabolites in the pathogenesis of nonalcoholic steatohepatitis  :   Martínez-Montoro JI, Kuchay MS, Balaguer-Román A, Martínez-Sánchez MA, Frutos MD, Fernández-García JC, Ramos-Molina B. Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery. Obes Rev. 2021:e13367. doi: 10.1111/obr.1336, 2021
  • Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals :   Kuchay MS, Martínez-Montoro JI, Choudhary NS, Fernández-García JC, Ramos-Molina B. Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines. 2021; 9(10):1346., 2021
  • Arch Endocrinol Metab  :   Kuchay MS, Mathew A, Kaur P, Mishra SK. Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism. Arch Endocrinol Metab. 2021:2359-3997000000408., 2021
  • The association between nonalcoholic fatty liver disease and cardiovascular disease :   Choudhary NS, Saraf N, Kuchay MS, Kasliwal RR. The association between nonalcoholic fatty liver disease and cardiovascular disease: A window of opportunity. J Clin Cardiol. 2021;10:112-116., 2021
  • Prevalence of clinically relevant liver fibrosis :   Kuchay MS, Choudhary NS, Mishra SK, et al. Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian Individuals with type 2 diabetes. JGH Open. 2021. https://doi.org/10.1002/jgh3.12606., 2021
  • Effectiveness of diabetes education :   Mishra M, Bano T, Mishra SK, Wasir JS, Kohli C, Kalra S, Choudhary P, Kuchay MS. Effectiveness of diabetes education including insulin injection technique and dose adjustment through telemedicine in hospitalized patients with COVID-19. Diabetes Metab Syndr. 2021 Jun 12;15(4):102174., 2021
  • Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and non-alcoholic fatty liver disease :   Kuchay MS, Choudhary NS, Gagneja S, Mathew A, Bano T, Kaur P, Bahadur B, Singh MK, Gill HK, Wasir JS, Sud R, Mishra SK. Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2021. doi: 10.1111/jgh.15595., 2021
  • Diabetes Metab Syndr :   Kuchay MS, Mishra SK, Mehta Y. Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery. Diabetes Metab Syndr. 2021;15(3):909-911., 2021
  • New-onset diabetes before the pandemic :   Ghosh A, Anjana RM, Shanthi Rani CS, Jeba Rani S, Gupta R, Jha A, Gupta V, Kuchay MS, Luthra A, et al. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study. Diabetes Metab Syndr. 2021;15(1):215-220., Click here for Publications Link
  • New onset diabetes, type 1 diabetes and COVID-19 :   Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr. 2020;14(6):2211-2217. , 2020
  • Standard management algorithms for type 2 diabetes. :   Kuchay MS, Choudhary NS, Mishra SK, et al. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. Diabetes Metab Syndr. 2020;14(6):2233-2239, 2020
  • New onset diabetes, type 1 diabetes and COVID-19 :   Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr. 2020;14(6):2211-2217., 2020
  • Diabetes Metab Syndr :   Kuchay MS, Choudhary NS, Mishra SK. Pathophysiological mechanisms underlying MAFLD. Diabetes Metab Syndr. 202024;14(6):1875-1887, 2020
  • Diabetic ketoacidosis precipitated by COVID-19 :   Reddy PK, Kuchay MS, Mehta Y, Mishra SK. Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature. Diabetes Metab Syndr. 2020;14(5):1459-1462, 2020
  • Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD :   Kuchay MS, Krishan S, Mishra SK, et al. Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). Diabetologia. 2020;63(11):2434-2445., 2020
  • From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD):  :   Kuchay MS, Misra A. From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years. Diabetes Metab Syndr. 2020;14(4):695?696, 2020
  • Low-dose ACTH test for evaluation of hypothalamus-pituitary-adrenal axis preoperatively  :   Garg A, Mishra SK, Dubey S, Singh VP, Kuchay MS, Mithal A. Low-dose ACTH test for evaluation of hypothalamus-pituitary-adrenal axis preoperatively and 3-month follow-up in non-functioning pituitary adenomas. J Endocrinol Invest. 2020 [published online ahead of print], 2020
  • Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors :   Kuchay MS, Farooqui KJ, Mishra SK, et al. Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors. Adv Exp Med Biol. 2021;1307:213-230., 2021
  • Nutritional aspects of calcium and vitamin D: global perspective :   Kuchay MS, Mithal A. Nutritional aspects of calcium and vitamin D: global perspective. Chapter 3, Bone and Mineral Disorders. 2019., 2019
  • Immediate postoperative complications following coronary artery bypass grafting in patients with type 2 diabetes :   20) Bano T, Kuchay MS, Mishra SK, et al. Immediate postoperative complications following coronary artery bypass grafting in patients with type 2 diabetes: a prospective cohort study. Diabetes Metab Syndr. 2019;14:47-51., 2019
  • lactate levels in patients undergoing coronary artery bypass graft surg Indian J Endocrinol Metab :   Bano T, Mishra SK, Kuchay MS, et al. Continuation of metformin till night before surgery and lactate levels in patients undergoing coronary artery bypass graft surg Indian J Endocrinol Metab. 2019;23(4): 416-421., 2019
  • Successful management of tumor-induced osteomalacia with radiofrequency ablation :   Mishra SK, Kuchay MS, Sen IB, et al. Successful management of tumor-induced osteomalacia with radiofrequency ablation: A case series. JBMR Plus. 2019;3(7):e10178., 2019
  • Clinical risk factors in the Indian population :   Bansal B, Mithal A, Chopra SR, Bhanot S, Kuchay MS, Farooqui KJ. Judicious use of DXA-BMD in assessing fracture risk by using clinical risk factors in the Indian population. Arch Osteoporos. 2018;13(1):115., 2018
  • Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease :   Kuchay MS, Krishan S, Mishra SK, et al. Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial). Diabetes Care. 2018;41(8):1801-1808., 2018
  • Pitfalls in interpreting interventional studies for osteoporosis :   Kuchay MS, Bansal B, Mithal A. Pitfalls in interpreting interventional studies for osteoporosis. Clin Cases Miner Bone Metab. 2017;14(3):329-331, 2017
  • Textbook of Emergency and Trauma Care :   Wasir JS, Kuchay MS, Aggarwal P. Hypoglycemia. Chapter 63, Textbook of Emergency and Trauma Care. 2017, 2017
  • The changing profile of hypercalcemia in a tertiary care setting in North India :   Kuchay MS, Kaur P, Mishra SK, Mithal A. The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study. Clin Cases Miner Bone Metab. 2017;14(2):131-135., 2017
  • Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia :   Kuchay MS, Mishra SK, Bansal B, Farooqui KJ, Sekhar L, Mithal A. Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia. Arch Osteoporos. 2017;12(1):68, 2017
  • Acute severe diarrhoea and hyponatremia after zoledronic acid infusion: an acute phase reaction :   Kuchay MS, Farooqui KJ, Mithal A. Acute severe diarrhoea and hyponatremia after zoledronic acid infusion: an acute phase reaction. Clin Cases Miner Bone Metab. 2017;14(1):101-104., 2017
  • The changing profile of hypercalcemia in hospital populations :   Kuchay MS, Farooqui KJ, Jevalikar G, Mithal A. The changing profile of hypercalcemia in hospital populations. Clinic Rev Bone Miner Metab. 2017;15:82-89., 2017
  • Levosulpiride and serum prolactin levels :   Kuchay MS, Mithal A. Levosulpiride and serum prolactin levels. Indian J Endocr Metab. 2017;19:693-695, 2017
  • Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis :   Kuchay MS, Farooqui KJ, Bano T, Khandelwal M, Gill H, Mithal A. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review. Arch Endocrinol Metab. 2017;61:198-201, 2017
  • Hypercalcemia of advanced chronic liver disease :   Kuchay MS, Mishra SK, Farooqui KJ, Bansal B, Wasir JS, Mithal A. Hypercalcemia of advanced chronic liver disease: a forgotten clinical entity! Clin Cases Miner Bone Metab. 2016;13(1):15-8., 2016
  • Gender differences in insulin and C-peptide concentrations at birth using cord blood collection :   Kuchay MS, Kudyar RP, Gupta A, et al. Gender differences in insulin and C-peptide concentrations at birth using cord blood collection. Arch Endocrinol Metab. 2016;60(3):264-266., 2016
  • Efficacy and safety of a single monthly dose of cholecalciferol in healthy school children :   Kuchay MS, Jevalikar GS, Mithal A, et al. Efficacy and safety of a single monthly dose of cholecalciferol in healthy school children. J Pediatr Endocrinol Metab. 2016;29(4):413-416., 2016
  • Hemoglobin E disease and glycosylated hemoglobin :   Yedla N, Kuchay MS, Mithal A. Hemoglobin E disease and glycosylated hemoglobin. Indian J Endocr Metab 2015;19:683-685., 2015
  •  Effect of Vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes :   Kuchay MS, Laway BA, Bashir MI, Wani AI, Misgar RA, Shah ZA. Effect of Vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes: A 1-year, open-label randomized study. Indian J Endocr Metab 2015;19:387-92., 2015
  • Recurrent myonecrosis involving adductor muscle group bilaterally :   Bhat M, Laway B, Kuchay M, Mir S, Dar F, Raja W. Recurrent myonecrosis involving adductor muscle group bilaterally: a rare complication of diabetes mellitus. Oman Med J 2014;29(6):445-449., 2014
  • Medical therapy alone can be sufficient for bilateral emphysematous pyelonephritis :   Bhat M, Laway B, Kuchay M, Mir S, Dar F, Raja W. Recurrent myonecrosis involving adductor muscle group bilaterally: a rare complication of diabetes mellitus. Oman Med J 2014;29(6):445-449., 2014
  • Rhabdomyolysis as a rare presentation of Distal Renal Tubular Acidosis :   Ahmad Bhat M, Ahmad Laway B, Mustafa F, Shafi Kuchay M, Mubarik I, Ahmad Palla N. Hypokalemic Quadriparesis and Rhabdomyolysis as a rare presentation of Distal Renal Tubular Acidosis. MJIRI 2014;28:35., 2014
  • Unsuspected celiac disease severely affects levothyroxine therapy in hashimoto’s thyroiditis :   Jha S, Waghdhare S, Kuchay MS, Siddiqui S. Unsuspected celiac disease severely affects levothyroxine therapy in hashimoto’s thyroiditis: a case report. Austin J Endocrinol Diabetes. 2014;1(5):1022., 2014
  • Incidence of Primary hypothyroidism in patients exposed to therapeutic external beam radiation :   42) Laway BA, Shafi KM, Majid S, Lone MM, Afroz F, Khan S, Roohi R. Incidence of Primary hypothyroidism in patients exposed to therapeutic external beam radiation, where radiation portals include a part or whole of the thyroid gland. Indian J Endocr Metab 2012;16:329-331., 2012
  • Association of polycystic ovary syndrome and Graves’ disease:  :   Nisar S, Shah PA, Kuchay MS, Bhat MA, Rashid A, Ahmed S, Ganie MA. Association of polycystic ovary syndrome and Graves’ disease: is autoimmunity the link between the two diseases. Indian J Endocr Metab 2012;16:982-986., 2012
  •  A case series of iatrogenic symptomatic hypercalcemia due to hypervitaminosis  :   K K Pandita, Sushil Razdan, R P Kudyar, Adil Beigh, Shafi Kuchay, Tanveer Banday. “Excess gooD can be Dangerous”. A case series of iatrogenic symptomatic hypercalcemia due to hypervitaminosis D. Clin Cases Miner Bone Metab 2012; 9(2):118–120., 2012
  • ESI manual of clinical endocrinology :   Two Chapters in ESI manual of clinical endocrinology, A. Polycystic ovary syndrome. B. Testosterone and Diabetes- emerging links.,

Special Interest

  • Diabetes Mellitus (type 2, type 1, gestational, and others)
  • Thyroid disorders, Pituitary and Adrenal Diseases
  • Adrenal disorders
  • Osteoporosis and Calcium Disorders
  • Polycystic Ovary Syndrome and other Endocrine Disorders

Similar Doctor

Related Doctors

Senior Director (Centre For Diabetes, Thyroid, Obesity & Endocrinology)

Senior Director (Centre For Diabetes, Thyroid, Obesity & Endocrinology)
Dr. Ashok Jhingan is a known name in the field of Endocrinology. He has devoted himself to the cause of reversing the rising incidences of Diabetes in Indian population, with selfless voluntary service to trigger a shift in mindset (habits & attitude) of general masses towards Diabetes.

Read more

Director (Endocrinologist) Centre For Diabetes, Thyroid, Obesity & Endocrinology

Director (Endocrinologist) Centre For Diabetes, Thyroid, Obesity & Endocrinology
Having successfully treated numerous patients, Dr. Ajay Kumar Ajmani is a leading name in the field of endocrinology and endocrine surgeries. He has been widely acknowledged for his versatile and patient-centric approach.

Read more

General Manager & Chief Dietician (Endocrinology and Diabetology)

General Manager & Chief Dietician (Endocrinology and Diabetology)
Sandhya Pandey has been working in the field Clinical Nutrition and Dietetics with a career span of more than 23 years. She is currently working as GM and chief clinical Nutritionist in Medanta -The Medicity, Gurgaon. She has worked with several prestigious institutes like Fortis memorial Research institute, Columbia Asia hospital, Max hospital and Indraprastha Apollo hospital prior to joining Medanta. She has worked in the field of research and extensive worked in the quality assurance programs in the hospital as well.

Read more

Associate Consultant (Endocrinology and Diabetology)

Associate Consultant (Endocrinology and Diabetology)
Dr. Rujul has rich experience and expertise in the field of both adult and paediatric endocrinology and has worked with various medical institutions of high repute. He also has numerous publications in reputed national and international journals with vast experience in working most prestigious institutions AIIMS, PGIMER & RML Hospital and has keen interest in treating diabetes in adults and children, thyroid disorders, pituitary and adrenal diseases, female and male reproductive system disorders, growth disorders and metabolic bone diseases

Read more

Consultant (Endocrinology and Diabetology)

Consultant (Endocrinology and Diabetology)
Dr. Harmandeep K Gill, MD (Internal Medicine), DM (Endocrinology), is currently working as consultant in Medanta’s Division of Endocrinology & Diabetes, Gurgaon. She has been trained in endocrinology at Sanjay Gandhi Post Graduate Institute of medical sciences (SGPGI), Lucknow. She brings along over 8 years’ experience in Endocrinology. Before joining Medanta, she was working as Assistant Professor in Endocrinology at University College of Medical Sciences (UCMS) & Guru Teg Bahadur Hospital (GTB), Delhi and also have a varied rich experience in working Metro Super Specialty Hospital, Noida. Her areas of expertise include Diabetes (Type 1, Type 2 and Gestational), Growth and Puberty Disorders including PCOS, Thyroid and Parathyroid Disorders, Osteoporosis, Pituitary and adrenal disorders

Read more

Director (Endocrinology and Diabetology)

Director (Endocrinology and Diabetology)
Dr. Jasjeet S Wasir is presently Director at the Division of Endocrinology and Diabetes at the prestigious Medanta The Medicity at Gurugram. He has done his formal medical training from All India Institute of Medical Sciences (AIIMS), Maulana Azad Medical College and University College of Medical Sciences. He is a primary faculty at the Center for Advanced Diabetes Therapy and Technology. Dr. Jasjeet has nearly 10 years of experience in the field of diabetes and metabolic diseases. Under the able guidance of Dr Ambrish Mithal he is spearheading the weight management programme at Medanta. His areas of expertise include weight management (Obesity) diabetes and heart attack risk factor assessment/control primary prevention of heart attack/diabetes newer and advanced therapy for diabetes management of complicated diabetes and in special situations like post transplant diabetes thyroid disorders PCOD etc. He has numerous publications in various high impact international national medical journals and has presented his original work at national and international forums.

Read more

Associate Director (Endocrinology and Diabetology)

Associate Director (Endocrinology and Diabetology)
Expertise in treating Diabetes (Type 1 and Type 2), Thyroid disorders and Parathyroid disorders, PCOS and Obesity. Nine years of work experience from AIIMS, New Delhi which includes MD (internal medicine) and DM Endocrinology Received A V Gandhi award For excellence in Endocrinology 2011 and MMS Ahuja Award For Best DM(Endocrinology) resident (AIIMS) 2011

Read more

Senior Director Division of Endocrinology & Diabetes

Senior Director Division of Endocrinology & Diabetes
Dr. Sunil Mishra is an MD (Internal Medicine, KGMC Lucknow) and a DM (Endocrinology & Metabolism) from AIIMS, New Delhi. He is currently working as Senior Director in the Division of Endocrinology & Diabetes at Medanta -The Medicity Gurugram. Before joining Medanta, Dr. Mishra was working as an Associate Professor at HIHT University Dehradun where he established Endocrinology and Diabetes specialties in the department of Medicine. He has over 18 years of experience in Endocrinology at prestigious institutes like AIIMS New Delhi, SGPGI Lucknow, HIHT University Dehradun and now at Medanta-The Medicity, since 2010. Dr. Mishra is available for providing expert opinion in uncontrolled diabetes mellitus, (type 1 and 2 diabetes mellitus), all types of thyroid disorders, menstrual irregularities(PCOS), pituitary disorders, calcium and metabolic bone disorders & Obesity.

Read more


ABOUT PERT MEDWELL


At Pert Medwell, our biggest reward is seeing you in the pink of your health. In this light, we give our complete dedication, determination and devotion into making sure that you receive the best medical treatment.



CONTACT


B-894, 1st Floor, Palam Extension, Sector 7, Dwarka,
New Delhi – 110075, India

Call Us on : +91 98107-24376
info@pertmedwell.com

© Copyright 2023. Pert Medwell